![Stefan Poehlmann Profile](https://pbs.twimg.com/profile_images/1363476466487484418/Q8pFiPYd_x96.jpg)
Stefan Poehlmann
@snpoehlm
Followers
220
Following
28
Statuses
37
Virologist, Head of Infection Biology Unit, Deutsches Primatenzentrum @DPZ_eu
Göttingen, Deutschland
Joined February 2021
RT @angie_rasmussen: Never thought I would see the day when Tony Fauci, a lifelong public servant who built NIAID into the global standard…
0
851
0
RT @chemRxivBiochem: Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease a…
0
1
0
@NeuroNNNNN_bot Important insights into antibody affinity and its link to neutralizing activity and broad, long-lasting immunity against SARS-CoV-2.
0
0
1
RT @NeuroNNNNN_bot: [PNAS] Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies https://t.co/…
0
4
0
RT @thevirallabbook: Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Reci…
0
1
0
RT @TheLancetInfDis: New correspondence: Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC http…
0
8
0
RT @alkharsah_k: Glad to see our paper published in @JVirology . We found out that mutations in the S protein of MERS-CoV could enhance it…
0
1
0
RT @EricTopol: First lab characterization of the effect of vaccination (JN.1-spike directed) on the emerging XEC variant
0
103
0
RT @behrens_georg: Interested in morde data about the new JN.1 vaccine? Thanks again to the entire team that made this real
0
5
0
RT @behrens_georg: So proud to share our preprint about the new Biontech omicron JN.1 vaccine. Many thanks to our team in Hannover, especia…
0
13
0
RT @behrens_georg: Just out. Our first characterisation of BA.2.87.1. Many thanks to Markus and Stefan @snpoehlm for their great work! http…
0
2
0
RT @CellCellPress: Now online! SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
0
15
0